The retina is a part of the central nervous system derived from the forebrain neural ectoderm.
8 Amacrine cells (ACs) are the important inhibitory intermediate neurons in the retina that could regulate visual information to RGCs, enabling elaborate visual functions. At present, there are more than 60 subtypes of ACs in the retina.
9 Despite their broad morphological diversity, ACs are often divided into three groups, including GABAergic ACs, glycinergic ACs, and non-GABAergic–non-glycinergic ACs, based on the expression of neurotransmitters. Although all types of ACs are generated from the multipotent retinal progenitor cells, they subsequently differentiate into different subtypes after combined action of the intrinsic and extrinsic factors during retinogenesis.
10–12 TFs are commonly used as the critical intrinsic components to regulate the cytogenesis, maintenance, and cell fate determination of retinal progenitors.
10 For instance, Foxn4 is required by retinal progenitor cells for the amacrine and horizontal precursors at early stages of retinogenesis.
13,14 Ptf1a has been shown to coordinate with the Prdm13 and together regulate the balance of inhibitory and excitatory neurons.
15,16 During retinogenesis, deficiency of
Prdm13 leads to a significant decrease in the number of CALBs
+ GABAergic or glycinergic ACs,
17 together with the Ebf3
+ ACs.
18 In addition, Barhl2 has been verified to play an important role in specifying both glycinergic and GABAergic ACs
19,20; meanwhile, Nr4a2 and Pax6 are involved in specifying GABAergic and glycinergic ACs, respectively.
21,22 Disruption in the balance of TFs including Six6, Vax1, Vsx2 or Otx2, could result in aberrant retinal development and retinal dysfunction, as well as microphthalmia.
23 Currently, the molecular mechanism of governing the specification or differentiation of ACs remains elusive.